Sarepta Therapeutics (SRPT) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28% |
| Dec 31, 2025 | 2.30% |
| Sep 30, 2025 | 3.44% |
| Jun 30, 2025 | 7.08% |
| Mar 31, 2025 | 4.28% |
| Dec 31, 2024 | 7.98% |
| Sep 30, 2024 | 10.58% |
| Jun 30, 2024 | 7.47% |
| Mar 31, 2024 | 5.25% |
| Dec 31, 2023 | 3.03% |
| Sep 30, 2023 | 3.80% |
| Jun 30, 2023 | 2.73% |
| Mar 31, 2023 | 1.26% |
| Dec 31, 2022 | 19.73% |
| Sep 30, 2022 | 22.85% |
| Jun 30, 2022 | 19.69% |
| Mar 31, 2022 | 15.88% |
| Dec 31, 2021 | 24.23% |
| Sep 30, 2021 | 31.05% |
| Jun 30, 2021 | 30.30% |
| Mar 31, 2021 | 28.60% |
| Dec 31, 2020 | 31.65% |
| Sep 30, 2020 | 51.46% |
| Jun 30, 2020 | 85.71% |
| Mar 31, 2020 | 79.28% |
| Dec 31, 2019 | 62.59% |
| Sep 30, 2019 | 51.74% |
| Jun 30, 2019 | 104.60% |
| Mar 31, 2019 | 109.57% |
| Dec 31, 2018 | 81.69% |
| Sep 30, 2018 | 85.69% |
| Jun 30, 2018 | 75.25% |
| Mar 31, 2018 | 74.98% |
| Dec 31, 2017 | 64.28% |
| Sep 30, 2017 | 35.87% |
| Jun 30, 2017 | 10.10% |
| Mar 31, 2017 | 22.93% |
| Dec 31, 2016 | 13.30% |
| Sep 30, 2016 | 16.97% |
| Jun 30, 2016 | 3.58% |
| Mar 31, 2016 | 3.34% |
| Dec 31, 2015 | 10.13% |
| Mar 31, 2015 | 73.28% |
| Dec 31, 2014 | 75.73% |
| Sep 30, 2014 | 73.51% |
| Jun 30, 2014 | 65.11% |
| Dec 31, 2013 | 85.10% |